Biomaterial Modifications and Improvement of Their Biocompatibility 2.0
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 279
Special Issue Editors
Interests: biomaterials; bone regeneration, stem cells; oxidative stress; apoptosis; neuroprotection; antitumoral drugs; cell culture; in vitro systems; flow cytometry
Special Issues, Collections and Topics in MDPI journals
Interests: biomaterials; bioceramics; biopolymers; tissue engineering; bone scaffolds; wound dressings; skin substitutes; stem cells; cell culture models; cell-biomaterial interactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose. Biomaterials may be natural or synthetic and are used in medical applications to support, enhance, or replace damaged tissue or a biological function. For years, biomaterials have been required to passively take over the function of a damaged tissue in the long term. However, the role that biomaterials play in the clinical treatment of damaged organs and tissues is changing, and biomaterials are currently expected to trigger and harness the self-regenerative potential of the body in situ. To this end, research is currently focused on changes in various aspects of biomaterials to improve their biocompatibility, i.e., the ability to perform with an appropriate host response.
This Special Issue’s Editors invite original contributions and review articles that address the modification of biomaterial aiming to enhance their biocompatibility in various fields of application. These include but are not limited to medical implants, healing and regeneration of human tissue, nanoparticles, and drug delivery systems.
Prof. Dr. Viviana di Giacomo
Prof. Dr. Agata Przekora
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- bone regeneration
- wound healing
- regenerative medicine
- cardiac valve
- skin
- nanoparticle
- drug delivery
- biocompatibility
